Ally Bridge Group (NY) LLC
CIK 1822947 · Holdings on Sep 30, 2023 · First reported Nov 14, 2023
Top ten holdings
Q3 2023- MLTX12.25%
- XENE10.70%
- ITCI10.70%
- AXSM9.07%
- APLS8.12%
- CYTK7.72%
- MRUS6.13%
- AMLX5.86%
- GERN5.53%
- ARDX4.22%
Share classes counted separately80.30%
Portfolio value by quarter
Top 10 holdings 19
USD · B = billion · M = million; expand a row for exact values| # | Security | Value | Weight | Quantity | Weight / quantity change | Activity | |
|---|---|---|---|---|---|---|---|
| 01 | MLTXMOONLAKE IMMUNOTHERAPEUTICSCLASS A ORD View history and evidence | $10.44M | 12.25% | 183.10K shares | — | ↗▾ | |
| 02 | XENEXENON PHARMACEUTICALS INC View history and evidence | $9.12M | 10.70% | 266.96K shares | — | ↗▾ | |
| 03 | ITCIINTRA-CELLULAR THERAPIES INC View history and evidence | $9.12M | 10.70% | 175.00K shares | — | ↗▾ | |
| 04 | AXSMAXSOME THERAPEUTICS INC View history and evidence | $7.73M | 9.07% | 110.60K shares | — | ↗▾ | |
| 05 | APLSAPELLIS PHARMACEUTICALS INC View history and evidence | $6.92M | 8.12% | 181.81K shares | — | ↗▾ | |
| 06 | CYTKCYTOKINETICS INCCOM NEW View history and evidence | $6.58M | 7.72% | 223.38K shares | — | ↗▾ | |
| 07 | MRUSMERUS NV View history and evidence | $5.22M | 6.13% | 221.38K shares | — | ↗▾ | |
| 08 | AMLXAMYLYX PHARMACEUTICALS INC View history and evidence | $4.99M | 5.86% | 272.69K shares | — | ↗▾ | |
| 09 | GERNGERON CORP View history and evidence | $4.71M | 5.53% | 2.22M shares | — | ↗▾ | |
| 10 | ARDXARDELYX INC View history and evidence | $3.60M | 4.22% | 881.36K shares | — | ↗▾ |
Options overlay 0
No options reported this quarter.
Exited positions 7
| Security | Type | Shares out | Value out | Previous filing | This filing |
|---|---|---|---|---|---|
| RETA REATA PHARMACEUTICALS INC-A | Non-derivative | — | — | SEC filing ↗ | |
| VRNA VERONA PHARMA PLC - ADR | Non-derivative | — | — | SEC filing ↗ | |
| VRDN VIRIDIAN THERAPEUTICS INC | Non-derivative | — | — | SEC filing ↗ |
3 / 7 preview exits. Up to 30 exit records are previewed. Exit means absent from the current filing; execution date, price and proceeds are unknown.
Every number has a source.
CIK 1822947 · Period 2023-09-30
Data loaded 2026-09-23 · First reported 2023-11-14
Amendments and versions
{
"amendments_merged": null,
"prior_versions": null,
"cover_table_value": 85197876
}Take these holdings further.
This page includes 19 of 19 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.
- Download CSV
- Earlier quarters
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#portfolio-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. This page lists 19 of 19 current positions (options included); totals and weights use the complete filing.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.
MCP https://api.akkrudata.ai/mcp
get_institutional_portfolio
{"cik":"1822947","quarter":"2023Q3","page_size":100}
get_institutional_manager_history
{"cik":"1822947","page_size":100}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.